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INTRODUCTION 
“Pain following surgery is a universal phenomenon and it is not 
just slapping the patient on the face and telling him or her that ‘it is all 
over’. As for as the patient is concerned, it is just the beginning”(Berry, 
1979) 
Pain is often underestimated and undertreated, and its intensity 
varies among people. Inadequate knowledge regarding the necessity and 
adequate pain relief, combined with difficulty in assessment of pain has 
resulted in undertreatment of pain.  
 Pain is perhaps the most feared symptom of disease and man has 
tried his level best to discover methods to relieve pain. Effective 
analgesia reduces postoperative morbidity and mortality.  Children need 
special care with regard to pain relief because of their lack of 
communicability.  
The mode of pain relief should be such that it is technically less 
harmful, has minimal side effects, makes the surgeon comfortable, has 
extended post operative comfort and also cost effective. Parents should be 
satisfied when the child is given back to them at the end of surgery. 
Regional technique was chosen as the sole  method of anaesthesia 
because of the simplicity, postoperative comfortability offered by 
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extended analgesia and to avoid the complications and side effects of 
general anaesthesia. 
 
Caudal block with local anaesthetic, when supplemented with 
adjuvants like Morphine, Tramadol, Fentanyl, Neostigmine have shown 
to be beneficial in various studies. Clonidine has established its own place 
as an adjuvant with local anaesthetics in various routes like intrathecal, 
epidural, nerve blocks, intravenous and orally. Hence this study was done 
to evaluate the efficacy of caudal Clonidine as an adjuvant to Bupivacaine 
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HISTORY 
1885 – CORNING first used epidural analgesia 
1901 – SICARD and CATHELIN described epidural injection through 
sacral hiatus. 
1920 – ZWEIFEL was able to analyse 4200 caudal epidural blocks and 
recorded it in literature. 
1921 – PAGES applied lumbar epidural analgesia in clinical surgery. 
1933 – CAMBEL M.F first described sacral epidural block in children 
and infants. 
1957 – synthesis of Bupivacaine. 
1963- Bupivacaine was used in clinical practice. 
1965 – MELZACK and WALL – propounded the Gate control theory of 
pain 
1974 – KAY B used caudal block for postoperative pain relief in children 
1979 – MICHAEL J.COUSINS demonstrated the successful use of 
epidural Morphine and analgesia ,correlated with CSF rather than 
plasmas concentration of the drug. 
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AIM OF THE STUDY 
 
To assess the efficacy and safety of Clonidine as an adjuvant for 
Bupivacaine when compared with plain Bupivacaine for caudal block in 
Paediatric infraumbilical surgeries. 
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ANATOMICAL CONSIDERATIONS 
EPIDURAL SPACE(Fig. 1) 
The epidural space is a potential space within the bony cavity of 
the spinal cord and outside dural sac. It extends from the foramen magum  
to the coccyx. Within the cranium the endosteal and meningeal layers are 
united but below the foramen magnum, the two layers are separate, the 
outer becoming periosteal layer of the spinal cord, while the inner layer 
forms the spinal duramater. Between these two layers lies the epidural 
space. The spinal canal is triangular in cross section and the epidural 
space is widest in midline posteriorly in the lumbar region averaging 
about 5 to 6 mm in diameter. In the midthoracic region, the distance is 
somewhat less in the range of 3 to 5 mm in midline. 
Boundaries of the epidural space: 
Above: the foramen magnum, where the periosteal and spinal layers of 
the dura fuse together. 
Below: the sacrococcygeal membrane 
Front : the posterior longitudinal ligament covering the posterior aspect 
of the vertebral bodies and intervertebral discs. 
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Behind: the anterior surface of vertebral  lamina and ligamentum flavum 
Laterally: the pedicles of vertebra and intervertebral foramina 
 
Fig. 1 EPIDURAL SPACE 
 
 
ANATOMY OF SACRUM(Fig. 2) 
Sacrum is a large wedge shaped bone formed by the fusion of five 
sacral vertebrae articulating above with 5th lumbar vertebra and below 
with the coccyx 
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It has concave anterior and convex posterior surfaces; the anterior 
surface bears four transverse lines (demarcating the boundaries between 
the fused bodies) which terminate on each side in four anterior sacral 
foramina. The anterior primary rami of the first four sacral spinal nerves, 
emerge from the anterior sacral foramina. 
The posterior surface is convex and in midline runs a bony ridge, 
the median sacral crest with 3 or 4 rudimentary spinous process. The 
lamina of the 5th and sometimes the 4th sacral vertebra fail to fuse in the 
midline. The deficiency thus formed is known as “sacral hiatus ”.The 
lateral margins of this space each bear a prominence – “sacral cornu” – 
which represents the remnant of the inferior articular process of the 5th 
sacral vertebra. 
Sacral canal                                                                                
        It is a prismatic cavity running throughout the length of the bone and 
following its curves. Superiorly, it is triangular in its section and is 
continuous with the lumbar epidural space. Its lower extremity is the 
sacral hiatus, closed by posterior sacro-coccygeal membrane. Fibrous 
bands may be present in the canal and divide the epidural space into loculi 
which prevent the spread of solution and  
Fig. 2  SACRAL CANAL 
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these may account for occasional incomplete anaesthesia. The anterior  
wall of the sacral canal is formed by the fusion of the scaral vertebrae and 
posterior wall is by fusion of laminae. 
Contents of the sacral canal 
1. The dural sac extends and ends at the lower end of 2nd sacral vertebra on a 
line joining the posterior superior iliac spine 
2. Sacral and coccygeal nerve roots with their dorsal root ganglia. 
3. The filum terminale which is the continuation of piameter 
4. Epidural plexus of veins formed by the lower end of vertebral veins. 
These vessels are numerous in anterior aspect than posteriorly and are 
valveless. 
5. Loose areolar and fatty tissue, which is more dense in males than in 
females 
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6. In infants the sacral canal is filled with fluid fat and areolar connective 
tissue, which allows easy spread of anaesthetic solutions. 
7. In older children of 6 -7 years of age, the epidural fat becomes more 
densely packed, thus reducing this spread. 
Sacral hiatus    
This is a triangular opening present in the posterior wall resulting 
from failure of fusion of laminae of the 5th sacral vertebra and sometimes 
the 4th sacral vertebra. Its apex is at the level of the spine of 4th sacral 
vertebra. In some cases the apex is at the level of 3rd sacral spine, due to the 
absence of the 3rd and 4th laminae and occasionally the whole of the bony 
posterior wall is deficient. When the laminae of the 5th sacral vertebra are 
almost fused in the midline, the hiatus may be very small with a diameter of 
as narrow as 2mm. 
         The hiatus is covered by the sacro-coccygeal membrane and pierced 
by the coccygeal nerves and the 5th sacral nerve. This membrane may be 
ossified in elderly subjects making the introduction of caudal needle 
difficult. 
When local anaesthetic is injected into the sacral canal, it ascends 
upwards in the sacral epidural space for a distance proportional to the 
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volume of the solution, force of injection, amount of leakage through the 
eight sacral foraminae and the connective tissue in the space. 
           The sacral canal may be wholly or partially obliterated by three 
anomalies. There may be a transverse fold in the posterior wall of the canal 
in conjunction with a forward projection of the corresponding segment of 
the sacral body, there may be a dorsal projection of a sacral vertebral body 
into the canal or there may be bony outgrowths which obliterate the hiatus. 
These anomalies may lead to incomplete caudal blockade or total failure. 
 
 
 
 
PHYSIOLOGICAL CONSIDERATIONS 
PAIN PATHWAYS 
Pain receptors consist of peripheral plexus of unmyelinated nerves, 
activated by high-intensity stimuli which may be thermal, mechanical, 
electrical or chemical. 
Pain is conducted along two types of fibres in the periphery, A 
delta fibres which are finely myelinated and relatively rapidly 
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conducting(12-30m/sec). They conduct the sharp pain produced by pin 
prick or electrical stimulation as well as thermal stimuli and responsible 
for withdrawal reflex. A delta conducted pain is felt quickly and is well 
localised. ‘C’ fibres are very fine non-myelinated fibres which conduct at 
a very slow rate 2-3m/sec or less. Their threshold for stimulation is higher 
and is responsible for delayed and truly noxious burning or throbbing 
pain. 
                The activation of two different type of fibres(A delta &C) by 
noxious stimuli explain the double sensation for pain evoked in human by 
a single short noxious stimulus: rapid pricking pain(0.1sec, latency, first 
pain) carried by A delta fibres is followed  approximately, 1 sec later by a 
burning pain (second pain) mediated by C fibres.   
Peripheral sensory nerves have their cell bodies in the dorsal root 
ganglion and the central projection of A delta and C fibre neurones enter 
the dorsal horn in the lateral division of the dorsal root.  
In the grey matter of the spinal cord, the cell bodies are arranged in 
a series of laminae, some of which have classical names but which are 
more simply given roman numerals by Rexed, starting with I at the tip of 
the dorsal horn. A delta and C  primary afferent fibres terminate 
principally in the marginal layer (lamina I) and the substantia gelatinosa 
(lamina II)(fig.3) Some of the neurons of the lamina I which synapse with 
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A delta fibres, give off axons which ascend in the contralateral anterior 
columns without synapsing with neurons from deeper layers. The 
majority of the pain fibres, however synapse in the substantia gelatinosa 
with intermediate neurons which send projections to deeper layers or with 
the dendrites of neurons whose cell bodies reside in deeper layers, 
principally in lamina V. 
The central projection from cell bodies in lamina IV, V & VI with 
contribution from lamina I, cross midline in the anterior commissure to form 
the spinothalamic tract, which ends in thalamus, principally in the 
ventroposterior nucleus, sending a few fibres, enroute, to the periaqueductal 
grey matter. The ventroposterior nucleus of the thalamus projects to the post 
central gyrus, the sensory cortex (fig 4) 
 
Fig. 3  PAIN FIBRES IN THE SPINAL CORD 
 
16 
 
 
 
Fig. 4  PAIN PATHWAYS 
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Pain stimuli can also pass via interneurons to cell bodies in the 
intermediate grey matter (laminae VII & VIII) whose central projections 
also ascend in the contralateral anterolateral columns, forming 
spinoreticular pathway. 
While it appears that the thalamus is involved in the experience of 
pain, the post-central gyrus is necessary for its accurate localization and 
prefrontal cortex for unpleasant affective reactions to it. 
INHIBITORY PATHWAYS: 
1. Large primary afferent fibres, which mainly ascend in the dorsal 
columns and whose cell bodies lie in the dorsal root ganglion, send 
collaterals to synapse with and activate inhibitory inter neurons in the dorsal 
horn. These inturn inhibit release of transmitter along pain pathways. Thus, 
18 
 
stimulation of large A beta cutaneous afferents may inhibit pain 
transmission(Gate theory of Melzack and Wall)(Fig.5) 
2. Inhibitory fibres, which descend in the dorsolateral white funiculus 
and whose cell bodies lie in the medullary raphe nuclei, may also inhibit 
pain transmission, presumably by an action of the inhibitory interneurons. 
Activity in these descending inhibitory fibres may be provoked by 
stimulation of the cell bodies in the medulla directly or of the periaqueductal 
grey matter. 
3. Endorphins : long axons originating in the Hypothalamus release 
endorphins into the third ventricle, which is conveyed to the spinal cord 
through   cerebrospinal fluid. This endorphin depresses pain conduction in 
Substantia gelatinosa. 
4. Fig.5  GATE CONTROL THEORY OF PAIN 
5.  
6.  
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7.  
8.  
9.  
10.  
 
 
 
PHYSIOLOGICAL CHANGES 
      While activity in sensory neurons may be excited in the periphery by 
thermoreceptor, nociceptor or mechanoreceptor stimulation, cell bodies in 
the posterior horn are responsive to different intensities of stimulation. Thus 
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certain cells, found principally in lamina IV respond only to a low intensity 
of stimulation such as light touch: These are termed low threshold or LT 
cells. They respond maximally to low- threshold stimuli and do not increase 
their firing rate with increased stimulus intensity. They are therefore 
incapable of conducting pain. Another type of cell, found principally in 
lamina V, responds over a wide range stimulus intensities, the so called 
wide-dynamic range or WDR cells.  Noxious stimuli can excite a variable 
response in WDR cells in lamina V. A third type of cell is responsive to 
stimuli only within the noxious range. Such cells are known as High 
threshold cells or HT cells and are found mainly in lamina I. A delta and C 
fibre stimulation in the periphery results in increased firing in HT and WDR 
cells in lamina I and V which is conducted up in spinothalamic tract. 
 Surgery produces local tissue damage with consequent release of 
algesic substances like prostaglandins, histamine, serotonin, bradykinin, 
hydroxytryptamine, substance P and generation of noxious stimuli that are 
transduced by nociceptors and transmitted by A delta and C fibres to the 
neuraxis.  
 L.glutamate is the only excitatory aminoacid which is concentrated in 
the dorsal horn. There are a number of receptors for glutamate namely 
NMDA(N-methly D-aspartate), AMPA(alpha amino-3 hydroxy-5 methyl-
isoxazole-4 – propionate), kainite, LAP4(L-2 amino-4-phopono butyrate) 
and metabotropic receptors. 
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 The majority of the opioid receptors in the dorsal horn are µ receptors 
although Delta and Kappa receptors are present.  
 Segmental reflex responses associated with surgery includes increased 
skeletal muscle tone and spasm with associated increase in O2 consumption 
and lacticacid production. Stimulation of sympathetic neuron cause 
tachycardia, increased stroke volume, cardiac work and myocardial oxygen 
consumption. 
 Suprasegmental reflex responses result in further increase in 
sympathetic tone and hypothalamic stimulation, metabolism and increased 
O2 consumption. Hence the most obvious motive for relieving postoperative 
pain is not only humanitarian but also contribute to more rapid and complete 
postoperative recovery after surgery. 
 
 
 
 
 
 
 
APPLIED PHARMACOLOGY 
PHARMACOLOGY OF BUPIVACAINE 
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 Bupivacaine was synthesised in Sweden by Ekenstam and his 
colleagues in 1957. It was introduced into clinical practise by L J Telivuo in 
1963. 
 The structure of Bupivacaine is the same as Mepivacaine, with a 
Butyl group replacing a methyl group in the Piperidine ring. This increases 
lipid solubility and protein binding. High potency is associated with high 
lipid solubility.( fig.6) 
PHYSICO CHEMICAL PROPERTIES 
Molecular Weight                                : 288 (base) 
Pka at 25°C                                           : 8.1 
Percentage of protein binding            : 95.6%  
Plasma protein binding                       : 2 µgm/ml 
Partition coefficient                            :27.5 (n-Haptane pH7.4 buffer) 
Apporoximate  anaesthetic duration: 175minutes. 
Site of metabolism                              : liver 
Safe dosage                                          :  2 - 3 mg/kg 
Toxicity                                                  :4-6 times more toxic   than      
Lignocaine. 
Bupivacaine is manufactured in concentration of 0.25% , 0.5% and 
0.75%. Autonomic blockade is produced by 0.125% solution and this has 
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been reported to relieve the pain of labour. Sensory blockade with very 
minimal motor blockade is  
Fig. 6  BUPIVACAINE 
 
 
provided by 0.25% solution. Motor blockade is provided by 0.5% 
solution. Bupivacaine has a much more pronounced effect upon sensory 
nerves than motor nerves, and intense anaesthesia may often be obtained 
without any motor blockade. This is a special advantage in the treatment of 
pain such as post operative, post traumatic and labour pain. 
 Duration of analgesia is between 5 and 16 hours and is the longest of 
any local anaesthetics known. It may be related to its increased protein 
binding. Commercially it is available as hydrochloride salt. Carbonated 
Bupivacaine is also available and is said to act intensely and in a widespread 
manner. Development of tachyphylaxis is much less common than with 
Lignocaine. 
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Action on the cardio vascular system 
 Bupivacaine is relatively more cardiotoxic than Lignocaine. It is a 
powerful myocardial depressant and this is made worse by hypoxia, 
hypercarbia and by pregnancy. Ventricular arrhythmias including ventricular 
fibrillation are more lethal forms of Bupivacaine toxicity. Bupivacaine 
induced convulsions is probably due to its high lipid solubility.  According  
to Moore et al (1979), an arterial plasma concentration of 5. 4 µgm/ml 
following an intravenous bolus of  Bupivacaine resulted in convulsions. The 
threshold arterial plasma level for Bupivacaine-induced convulsions is 
4µgm/ml. 
 
Safety dosage: (2.5mg/kg) 
  The blood concentration associated with maximum effective dose (c 
max) is 0.7µgm/ml (ie; 3mg/Kg of 0.5-0.75% Bupivacaine). The blood 
concentrations associated with early signs of toxicity (c tox) with the same 
dose of drug is 1.6µgm/ml. The toxicity ratio of Bupivacaine is (c tox / c 
max) 2.3 (Tucker et al).  However recent studies indicate that higher doses 
of Bupivacaine 3mg/kg may be used provided direct vascular injection is 
carefully avoided.   Eyres RL et al found that during epidural analgesia , 
when using 3mg/kg of bupivacaine ,the mean plasma levels of 1.2-1.4 
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µgm/ml were reached, which are well within the limits of projected toxic 
levels. 
METABOLISM 
 Breakdown of bupivacaine is similar to that of mepivacaine and 
commences with removal of the piperidine side chain. The product 
pipecolyxylidine (PPX) is approximately one-eighth  as toxic as 
bupivacaine. PPX and unchanged bupivacaine are slowly excreted in about 
equal proportions in the urine. Reynolds (1971), Boyes (1975) reviewed the 
metabolism of Bupivacaune. Hyroxylation of the aromatic ring is believed 
to take place in case of Bupivacaine as with Lignocaine to produce a 
compound that can be conjugated and made water soluble.  Rothenstein 
(1983)  demonstrated that the human lungs extracted local anaesthetic from 
circulation and subsequently released it back into circulation. It is seen with 
Bupivacaine also. For Bupivacaine the first pass pulmonary extraction is 
dose dependent suggesting that uptake process become saturated rapidly 
(Rothenstein 1984). 
 Propranolol impairs Bupivacaine extraction by lungs, perhaps 
reflecting a common receptor site for the two drugs. The conjugated water 
soluble metabolite  N-desbutyl Bupivacaine  is extracted in urine and it is 
less than 40 % of the total local anaesthetic dose. 
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MECHANISM OF ACTION OF LOCAL ANAESTHETICS                     
The sequence whereby clinically used local anaesthetics produce inhibition 
of axonal conduction has been summarised by Corvino as follows.  
 1. Clinically all local anaesthetics exist in solution in both charged and 
uncharged forms, the relative proportions depending on the pH of the 
solution, the pH at the site of injection and Pka of each drug. The cation is 
responsible for most of the nerve blocking effect. 
 2. The uncharged lipophilic tertiary base form diffuses more readily across 
neural sheaths and the axonal membrane to reach the internal aspect of the 
sodium channel. The base is protonated within the cytoplasm and binds as 
the charged cation to a specific receptor within the internal opening of the 
sodium channel and thereby inhibiting sodium conductance. The loss of 
membrane permeability to sodium prevents cell membrane depolarisation 
and propagation of action potential. 
 3. The clinically used local anaesthetics act primarily on specific receptors 
located at the internal opening of sodium channel. Other possible sites of 
action include, 
A) Non-specific absorption within the cell membrane lipids resulting in 
membrane expansion and channel narrowing. 
27 
 
B) Diffusion of the uncharged base via hydrophobic pathways through 
membrane lipids to reach the specific receptor site, where 
protonation and binding occur within the internal opening of the 
sodium channel. 
1.The surface charge theory: this theory states that, the lipophilic portion 
of the anaesthetic molecule, penetrates the axonal membrane and the 
positively charged terminal aminoacid group of the molecule neutralises the 
negative charges present on  the axolemmal surfaces. An accumulation of 
suuficient positive charges would tend to neutralise the relatively 
electronegativity of the external membrane surface, resulting in an increase 
in the trans membrane potential without altering the intracellular resting 
potential. A sufficient increase in the transmembrane potential would inhibit 
the ability of an electric current from a nearby unanaesthetised portion of the 
nerve membrane to depolarise the treated area to its threshold for firing. 
Conduction blockade would then result. The surface charge theory requires 
that the charged form of local anaesthetic be the active form. 
 
PHARMACOLOGY OF CLONIDINE HYDROCHLORIDE 
Introduction:  
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             Clonidine hydrochloride is a centrally acting selective partial α₂ 
agonist introduced in early 1960s, It was during its use as a nasal 
decongestant that its anti-hypertensive property was found out. 
Subsequently more insights into the pharmacological properties has led to 
its use in clinical anaesthesia practice as well.  
          Clonidine hydrochloride is an imidazoline compound and exists as 
a mesomeric compound. The chemical name is 2-(2,6- 
dichlorophenylamino)-2-imidazoline hydrochloride. The structural 
formula is C9H9C12N3HCl.(Fig.7) 
        The molecular weight is 266.56. Clonidine is an odourless, bitter, 
white, crystalline substance, soluble in alcohol and water. Clonidine 
improves the quality of anaesthesia, provides a more stable 
cardiovascular course during anaesthesia and reduces the dose 
requirement of the anaesthetic agent. In fact Clonidine may reduce the 
MAC of halothane by upto 50% in a dose dependent manner. Clonidine 
potentiates the anaesthetic action of  the local anaesthetics with fewer side 
effects in peripheral nerve blocks and central neuraxial blockade. 
 
 
F ig.7  CLONIDINE HYDROCHLORIDE 
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Availability:        Available as 1ml ampoule containing 150 micrograms. 
It should be stored below 25oc. Tablet form is available for oral use. A 
transdermal delivery system is also available. 
Mechanism of action: 
        Clonidine is a centrally acting selective partial α₂ adrenergic agonist 
with a selectivity ratio of 220: 1 in favour of α₂ receptors.  The three 
subtypes of α₂ receptors are α₂A, α₂B, α₂C. α₂A receptors mediate  
sedation, analgesia,  sympatholysis . α₂B receptors mediate 
vasoconstriction and anti- shivering. The startle response may reflect the 
activation of α₂C receptors.   The drug is lipid soluble, penetrates the 
blood brain barrier to reach the hypothalamus and medulla when injected 
epidurally.  It stimulates the inhibitory α₂ adrenoreceptors to reduce the 
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central neural transmission in the spinal neurons.  Inhibition of substance- 
P release is believed to be involved in the analgesic effect.  
  The α₂ adrenoreceptors are located  on the afferent terminals of  
both peripheral and spinal neurons in the superficial laminae of the spinal 
cord and within several brain stem nuclei implicated in analgesia.  The 
superficial laminae contain three group of neurons: tonic, adapting, 
single- spike firing, all of which receive their primary sensory input from 
Aδ and C fibres. Studies in rat models show that Clonidine inhibits 
voltage gated Na+ and K+ channels and suppresses the generation of 
action potentials in tonic- firing spinal dorsal horn neurons, contributing 
to analgesic effect. 
            Another contribution to analgesic effect may be through the 
release of acetylcholine in the neuraxial region. The α2 adrenergic 
agonists also enhance analgesia from intraspinal opioids. Sedation is 
produced by its action on locus ceruleus.  
         Clonidine affects the blood pressure in a complex fashion after 
neuraxial or systemic administration because of opposing action at 
multiple sites.  In the nucleus tractus solitarius and locus ceruleus of the 
brain stem, activation of post- synaptic α₂ adrenoreceptors reduces 
sympathetic drive. It also activates nor-adrenergic imidazoline preferring 
binding sites in the lateral reticular nucleus producing hypotension and 
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anti- arrythmogenic action. In the periphery it acts on pre-synaptic  
α₂adrenoreceptors at sympathetic terminals and reduces the release of 
nor-epinephrine, causing vasorelaxation and reduced chronotropic drive. 
The brainstem and the peripheral effects of α₂ adrenoreceptor stimulation 
are counterbalanced by the direct peripheral vasoconstriction through its 
action on α₂ adrenoreceptors from the circulating concentrations of 
Clonidine.  
    As a result the dose response for Clonidine by neuraxial or 
systemic administration is U-shaped, with peripheral vasoconstriction 
from circulating drug concentrations at high doses opposing central 
sympatholysis. 
PHARMACODYNAMICS: 
        The analgesic effect of Clonidine is more potent after neuraxial 
administration indicating a spinal site of action, favouring neuraxial 
administration, though it is possible to achieve analgesia from systemic 
administration as well. 
 
General:  
Clonidine is observed to be approximately twice as potent given 
epidurally as intravenously. 
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Cardiovascular system:  
Clonidine has minor or no effects on responses to vasoconstrictors 
or atropine given to treat hypotension or bradycardia  respectively, that 
may occur with neuraxial anaesthesia. 
Sedation:   
This is a desired property. Clonidine produces a dose dependent 
sedation at the dose of 50µg or more in less than 20 minutes regardless of 
the route of administration. 
Respiration:  
Clonidine  doesn’t induce profound respiratory depression even 
after massive overdose nor does it potentiate respiratory depression from 
opioids. 
Peripheral nerves:   
It produces a minor degree of blockade at high concentrations with 
some preference for C- fibres in the peripheral nerves and this effect in 
part enhances the peripheral nerve block when added to local 
anaesthetics, probably because the α₂ adrenoreceptors are lacking on the 
axons of peripheral nerves. 
PHARMACOKINETICS 
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           Clonidine is well absorbed orally and is nearly 100% bio available. 
The mean half life of the drug in plasma is about 12 hours. It is excreted 
in an unchanged form by the kidney, and its half- life can dramatically 
increase in the presence of impaired renal function.  
 A transdermal delivery system is available in which the drug is 
released at a constant rate for about a week. Three or four days are 
required to achieve steady state concentration. 
        Clonidine is highly lipid soluble and readily distributes into extra- 
vascular sites including the central nervous system. 
 Metabolism : it is metabolised through  minor pathways with the major 
metabolite, p- hydroxyclonidine. 
Excretion:  70% of the dose, mainly in the form of unchanged parent 
drug (40-60%)is excreted in urine. 
      So, the elimination t1/2 of Clonidine varies as a function of creatinine 
clearance. In subjects undergoing hemodialysis only 5% of the body 
Clonidine store was removed. 
 
 
ADVERSE EFFECTS:  
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The general adverse effects include weakness, fatigue, headache and 
withdrawal syndrome, pallor, a weakly positive coomb’s test and fever. 
1.Cardiovascular:  palpitations, tachycardia, bradycardia about 5 in 
1000, syncope, Raynaud’s phenomenon, congestive heart failure, ECG 
abnormalities like sinus node arrest, junctional bradycardia , high degree 
AV block and arrhythmias are reported rarely.               
2.Central nervous system: nervousness, agitation, mental depression, 
insomnia, vivid dreams or night mares, anxiety, visual and auditory 
hallucinations have been reported rarely. 
3.Dermatological: rash, angioneurotic edema, pruritus, urticaria and 
alopecia rarely. 
4.Gastro intestinal tract: nausea and vomiting, anorexia, malaise, 
transient abnormalities in liver function tests, hepatitis, parotitis and 
constipation. 
5.Genitourinary:  decreased sexual activity, impotence, loss of libido, 
nocturia. 
6.Hematlogic: thrombocytopenia rarely. 
7.Metabolic: weight gain and gynaecomastia, 
8.Musculoskeletal: muscle or joint pain, leg cramps. 
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9.Oro-otolaryngeal: dryness of the nasal mucosa. 
10.Opthalmological: dryness, burning of eyes. 
PRECAUTIONS: 
In patients with renal insufficiency, lower dose is needed. Sudden 
withdrawal of clonidine after prolonged continuous epidural infusion, 
produces hypertensive crisis. So the drug should be gradually 
discontinued over 2 to 4 days. It is used with caution in patients with 
cerebrovascular or coronary insufficiency. When infused into upper 
thoracic spinal segments clonidine produces pronounced decrease in 
blood pressure. 
If a patient on beta blocker therapy is given clonidine as continuous 
epidural, beta blocker should be withdrawn several days before instituting 
epidural Clonidine. 
Intrathecal and epidural Clonidine often causes bradycardia and if 
symptomatic it can be treated with inj. Atropine. 
CONTRAINDICATIONS: 
Clonidine is contraindicated in patients with known 
hypersensitivity to Clonidine or components of the product, in patients 
with brady arrhythmia or AV block, patients with severe cardiovascular 
disease, and in patients with cardiovascular or hemodynamic instability. 
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Epidural Clonidine above C4 level is contraindicated because there 
are no safety data to support such use. 
INTERACTIONS:    
 Clonidine may potentiate the CNS- depressive effect of alcohol, 
barbiturates or other sedative drugs. Narcotics may potentiate the 
hypotensive effects of Clonidine. Tricyclic antidepressants  may 
antagonize the hypotensive effect of Clonidine. Concomitant 
administration of drugs with a negative chronotropic or  dromotropic 
effect (beta blockers, digoxin) can cause or potentiate bradycardiac 
rhythm disturbances. Beta blockers may potentiate the hypertensive 
response seen with Clonidine withdrawal. Epidural Clonidine may 
prolong the duration of pharmacologic effects of epidural local 
anaesthetics, opioids, neostigmine and other drugs.  
INDICATIONS: 
1. To prolong the duration of epidural or spinal anaesthesia and 
Peripheral nerve block 
2. As adjuvant for the treatment of intra operative and post 
operative pain. 
3. Treatment of intra articular pain. 
4. In epidural,as an add on agent for relief of severe cancer pain. 
5. As an anxiolytic. 
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6. For sedation. 
7. To prevent or treat shivering. 
8. Treatment of hypertensive crisis 
Anaesthetic uses: 
1.Premedication: clonidine produces sedation by acting on locus 
ceruleus. It also produces  anaesthesia- sparing effect. 
2.Control of hemodynamics: clonidine  prevents hypertension and 
tachycardia during laryngoscopy and intubation as well as during surgical 
stimulation. Hence there is a decreased incidence of myocardial ischemia 
in cardiac and vascular surgeries. 
3.Epidural:clonidine is used  as a sole agent or in combination with 
opioids or local anaesthetics to provide excellent analgesia for labour pain 
and also for treating postoperative pain. 
4.Spinal: when used with local anaesthetics, Clonidine improves the 
quality and duration of the block, minimizes the tourniquet pain during 
lower limb surgery, and prevents shivering. 
5.Caudal:  when combined with local anaesthetics,clonidine increases the 
duration of anaesthesia and analgesia by 2 or 3 times without hemo 
dynamic side effects. Dose 2-3 µg/kg 
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6.Peripheral nerve blocks: clonidine  prolongs the duration of 
anaesthesia and analgesia with local anaesthetics by two times in a dose 
of 75 to150 µgm. 
7.Bier’s block: 150µg enhance the tolerance of tourniquet. 
Overdosage and treatment: 
There is no specific antidote for Clonidine overdosage. Supportive 
measures like atropine, ephedrine, i.v fluids is enough.  For hypertensive 
crisis i.v furosemide, diazoxide, phentolamine can be used.  
Yohimbine   partially reverses the analgesia and sedation but not 
the BP and heart rate changes produced by the epidural Clonidine. 
Naloxone may be a useful  for the management of Clonidine -
induced respiratory depression, hypotension and  coma.Blood pressure 
should be monitored after injecting naloxone as it may produce 
paradoxical hypertension. 
 
CAUDAL ANAESTHESIA 
Selection of equipment: 
Reliability of the technique and the incidence of complications largely 
depend on the characteristics of the needle used. The four important 
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characteristics of the needle are – bevel, internal &external diameter, length, 
presence of stylet 
Sharp bevelled needle: 
The advantage of a sharp bevel needle is that it traverses easily through the 
tissues. But the disadvantages are,  
• Characteristic “giveway” while puncturing sacrococcygeal membrane 
may not be clearly felt with sharp needles 
• Sharp needles have long bevel and hence it may have to be  advanced 
further into the epidural space so that it lies entirely within it 
• Cartilaginous sacrum can be easily traversed by a sharp and long 
bevelled needle which can lead to rectal puncture or iliac vessel 
puncture 
Hence straight tipped needle with a bevel of 45-60 degree is ideal 
Diameter: Small  needles may bend and break during the procedure. 
Thus, 21 to 23G is ideal because it is rigid and large enough to allow reflux 
of blood or cerebrospinal fluid. 
Length: The proximity of dural sac makes it dangerous to use very long 
needles. Distance from the skin to the epidural space is almost always less 
than 20mm, even in adults. So it is not advisable to use a needle longer than 
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30mm. Needle with stylet ,prevents formation of an epidermoid tumour due 
to skin tag. 
Epidural needle with 20 to 22G are employed when one intends to use an 
epidural catheter via caudal route to achieve anaesthesia at higher level 
after radiographic confirmation 
Determination of the volume of local anaesthetics: 
The height of block – depends on the volume injected 
Formula based on weight or age:  
Armitage, 1979  
High sacral – 0.5 ml/Kg 
High lumbar – 1ml/kg 
Thoracic level – 1.25ml/kg 
Sclhute-Steinberg formula (upto 8-12 years), 1977 
For children less than 7years, weight will be the best predictor 
Volume required in ml = 0.65 X number of segments to be blocked x body 
weight(kg) 
Speigal formula: 
Total volume of injection(ml)= 4+(D-15)/2 
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Where D is the distance separating the sacral hiatus from the spinous 
process of 7th cervical vertebra 
Modified Spiegal formula: 
Volume of injection (ml) = 4+(D-13)/2 
Despite larger volumes of local anaesthetics used in children as 
compared to adults, peak plasma levels of the local anaesthetics in children 
remain far below the toxic levels in adults 
As the child grows, the epidural space become less compliant and 
hence a   large volume can cause high spread of solution and an increase in 
the CSF concentration. Normal volume recommended for injection is 20ml 
Patient position: 
Lateral decubitus position or prone position with pillows underneath 
the hip and the foot inverted to relax the gluteal muscles is used to perform 
the caudal technique. 
Anatomical landmarks(Fig. 8) 
The posterior superior iliac spines form an equilateral triangle with 
the sacral hiatus. Intergluteal fold is not an ideal landmark because it will 
not always  
Fig.8  ANATOMICAL LANDMARK FOR CAUDAL BLOCK 
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correspond to the midline. Left forefinger placed in coccyx tip, hiatus 
corresponds to the second crease of finger. Palpation of this membrane gives 
a characteristic feel of a membrane under tension similar to that of a 
fontanelle, the point of puncture is at the midpoint of this triangular space 
TECHNIQUE(Fig. 9) 
The area is prepared with antiseptic solution. Sterile drapes are placed 
around the site.The skin is punctured with the needle initially at an angle of 
45° to the skin and the needle is advanced. Once needle crosses the 
sacrococcygeal membrane, a “give” is felt after which the needle is lowered 
to an angle of 20°-30° with the skin.. This is done to prevent the needle 
hitching against the anterior aspect of sacrum. The needle is advanced not 
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more than 2 -3 mm so as to ensure that the entire bevel is within the sacral 
canal. 
Confirmation of space: 
Whoosh test: this is done by injecting 7ml of air via the needle and 
auscultating just proximal to injection site, where a whoosh sound is heard. 
Swoosh test: Auscultation at a site just proximal to hiatus, while injecting 
local anaestheic produces a swoosh sound. The swoosh test is useful in 
children which avoids air injection into the epidural space. Air injection may 
cause a patchy block, venous air embolism and a rare complication of 
pneumocephalus if a large volume of air is injected. 
FIG. 9 TECHNIQUE OF CAUDAL BLOCKADE 
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Injection of drug: 
      After gentle aspiration, the drug is injected over a period of 60-90sec, 
irrespective of the volume injected (0.023-0.33ml/sec). The syringe should 
be repeatedly aspirated during the course of injection 
The patient is monitored for any change in BP or heart rate. Faster 
injection causes increased cephalad spread resulting in high block and 
respiratory problems. Transient increase in intracranial pressure with 
transient loss of consciousness or headache can occur. 
    On the other hand, too slow an injection increase the chances of 
lateralisation of the block or a lower level of anaesthesia since the drug 
tends to leak through the foramina or increase the risk of needle 
displacement 
Indications: 
Ideal for lower abdominal or lower limb surgeries 
Emergency: testicular torsion, strangulated hernia repair, paraphimosis, 
wound debridement of pelvis or lower limbs 
Elective: 
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Repair of inguinal hernia, umbilical hernia, hydrocele, orchidopexy, 
anorectal, genitourinary surgery, pelvic or hip or lowerlimb surgery, 
phimosis. 
 
Contraindications: 
Hydrocephalus, seizure disorders, vertebral osteosynthesis. 
Local skin infection,  pilonidal sinus near hiatus, major sacral malformation 
- meningomyelocele, meningitis.  
Spinabifida occulta is not a contraindication 
COMPLICATIONS 
Possibilities due to errors in technique: 
i. Subcutaneous injection  
ii. Vascular puncture: 10-15%. Since epidural veins are valveless, 
injection is immediately followed by convulsions, arrhythmias, 
hypotension, respiratory depression. 
iii. Dural puncture:  If dura is punctured, withdraw the needle 
immediately. 2nd attempt can be made provided the drug is injected 
slowly under low pressure.  Subarachnoid injection may lead to total 
spinal , even along cranial nerve distribution 
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iv. Bone marrow or rectal or intra osseous injection. 
Complete or partial failure of the block 
More common in > 7 years old 
Success rate increases or failure rate decreases with experience 
Lateralisation: occurs in 1 in 1000 cases 
When caudal is performed in lateral decubitus, 50% have a level of 
anaesthesia 2 dermatomes higher on the dependent side. 
When the injection is given slowly, the difference may be more than 4 
dermatomes ; this may be due to the presence of a complete plica mediana 
dorsalis 
Unanaesthetised dermatomes: L5, S1 may go unanaesthetised because of 
the large size. 
Other complications are Vomiting, epidural infection or meningitis, and 
shivering. 
REVIEW OF LITERATURE 
1.Caudal Clonidine Prolongs Analgesia from Caudal S(+)-Ketamine 
in Children     Helmut Hager, MD, Peter Marhofer, MD, Christian 
Sitzwohl, MD, Leo Adler, MD, Stephan Kettner, MD, and Margot 
Semsroth, MD        Anesthesia-Analgesia  2002;94:1169 –72    
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Fifty-three children (1–72 mo) scheduled for inguinal hernia repair were 
caudally injected with either S(+)-Ketamine 1mg/kg alone (Group K) or 
with additional Clonidine (Group C1 =1 µg/kg) Group C2 =2 µg/kg) 
during Sevoflurane anesthesia via a laryngeal mask. The mean duration of 
postoperative analgesia was 13.3 ± 9.2 h in Group K, 22.7 ±3.5 h in 
Group C1, and 21.8 ± 5.2 h in Group C2. Groups C1 and C2 received 
significantly fewer analgesics in the postoperative period than Group K. 
2. Caudal bupivacaine supplemented with caudal or intravenous 
Clonidine in children undergoing hypospadias repair: T. G. Hansen,  
S. W. Henneberg, S.Walther‐Larsen,  J. Lund and  M. Hansen et al . 
British journal of Anaesthesia 2004; 92: 223–7   Forty‐six children 
(ASA I or II) aged 24–104 months received standardized premedication 
with midazolam, a general anaesthetic and a caudal block with 
Bupivacaine 0.25%, 0.5 ml/ kg. The children were randomized in a 
double‐blind fashion to two groups: the i.v. group received Clonidine 2 
µg/ kg i.v. and simultaneously the same volume of saline caudally. The 
caudal group received Clonidine 2 µg/ kg caudally and a similar volume 
of saline i.v. They concluded that the analgesic effect of clonidine 2 
µg /kg as an adjunct to caudal block with Bupivacaine 0.25%, 0.5 ml/ kg 
is similar whether administered i.v. or caudally. 
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3.Analgesic effect of clonidine added to bupivacaine 0.125% in 
paediatric caudal blockade.  Joshi W, Connelly NR, Freeman K,  
Reuben SS. Paediatric Anaesthesia. 2004 Jun;14(6):483-6. 36 children 
undergoing elective surgery were studied. Following anaesthetic 
induction, a caudal was placed (1 mg/kg of bupivacaine 0.125%) with an 
equal volume of either clonidine (2µ.kg) or saline. There was no 
difference in analgesic duration between groups. There were significantly 
more children who vomited during the first 24 postoperative hours in the 
clonidine group than in the saline group (eight in clonidine, two in saline; 
P < 0.05).In  this study, they do not recommend adding clonidine (2 
microg.kg(-1)) to a bupivacaine (0.125%) caudal block in children 
undergoing surgery. 
4. Clonidine increases duration of bupivacaine caudal analgesia for 
ureteroneocystostomy: a double-blind prospective trial Tripi PA, 
Palmer JS, Thomas S, Elder JS. Journal of Urology. 2005 
Sep;174(3):1081-3.  A total of 35 children 1 to 10 years old undergoing 
ureteroneocystostomy received a standardized regimen of general 
anesthesia, and were randomized to receive a preincision caudal block 
consisting of either 1 ml/kg 0.125% Bupivacaine+ 1:4,00,000 epinephrine 
(controls) or 1 ml/kg 0.125% Bupivacaine +1:4,00,000 epinephrine with 
1 µg/kg clonidine (treatment group). Following the surgical procedure a 
49 
 
second caudal block was performed with half of the original dose of 
medications.  They concluded that the addition of Clonidine to 
Bupivacaine significantly increases the duration of caudal analgesia and 
decreases postoperative parenteral morphine requirements in children 
undergoing ureteroneocystostomy. 
5.A Comparison of Single-Dose Caudal Clonidine, Morphine,or 
Hydromorphone Combined with Ropivacaine in Pediatric Patients 
Undergoing Ureteral  Reimplantation  Thomas R. Vetter, MD Daniel 
Carvallo, MD Jodie L. Johnson, MD Michael S. Mazurek, MD Robert G. 
Presson, Jr., Anesthesia Analgesia 2007;104:1356 –63  
 Patients aged 6 mo to 6 yr were evenly and randomly enrolled in a 
double-blind manner. Patients received a single caudal dose of 2 mcg/kg 
of Clonidine, 10 mcg/kg of hydromorphone, or 50 mcg/kg of morphine, 
combined with 1.0 mL/kg of 0.2% Ropivacaine with epinephrine. No 
difference was observed in pain scores, total morphine use, time to first 
oral intake or discharge home. No postoperative respiratory depression, e 
xcessive sedation, hypotension, or bradycardia was identified. 
6.Caudal clonidine for open hip reduction in pediatric patients  
González-Flores ML, Peralta-Zamora E, Zaragoza-Lemus G, Flores-
Hernández SS  Review of Mexican Anesthesia 2007; 30 (4): 201-207 
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The study was conducted with forty-six children, aged 1 to 8 years 
scheduled for open reduction of the hip. Group I caudal block was with 
bupivacaine 0.25% 1.4 mL/kg and group 2 caudal block was with 
clonidine 2 µg/kg plus bupivacaine 0.25% 1.4mL/kg. Anesthesia was 
maintained with sevoflurane 1-1.5 vol%.  Group 2 had longer duration of 
analgesia than group 1 (13.06 vs 7.65 h). The blood pressure and cardiac 
rate were lower in group 2 (p<.05Group 2 had longer sedation. They 
concluded that adding clonidine (2 µg/kg) to bupivacaine (0.25% 1.4 
ml/kg) provided good post-surgical analgesia without significant 
haemodynamic changes. 
7.The Effect of Bupivacaine-Clonidine Combination in Quality and 
Duration of Caudal Block in Children between 2-7 Years Old 
SEYEDHEJAZI M, MD,  KALAMI L, MD NEGARGER S, MD 
ASLANADADI S, NAGIZADEH S, MD Journal of  Tabriz University 
of Medical Sciences, Vol. 30 No. 2,Summer 2008: 100 children aged 2-
7 years, scheduled for elective lower abdominal surgery, were assigned in 
two equal groups to receive 0.25% bupivacain 1ml/kg combined with 
either clonidine 2μg/kg (group 1)or 1ml normal saline (group 2). 3 
patients (6%) in group 1(first 1-2hours) and 21patients(42%) in group 
2(up to 
8 hours) required supplementary analgesia after operation ( P<0.001).  
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there were significant differences between two groups in the mean of 
systolic blood pressure (P<0.01), diastolic blood pressure(P<0.013). and 
heart rate(P<0.001) it was concluded  that when added to bupivacaine, 
clonidine improves the efficacy and lengths of caudal analgesia in 
children. 
8.Addition of Clonidine or Dexmedetomidine to Bupivacaine 
prolongs caudal analgesia in children A. M. El-Hennawy, A. M. Abd-
Elwahab, A. M. Abd-Elmaksoud, H. S. El-Ozairy  and S. R. Boulis  Br J 
Anaesth 2009; 103: 268–74    Sixty patients (6 months to 6 yr) were 
randomly assigned into three groups. each patient received a single caudal 
dose of Bupivacaine 0.25%  (1 ml/kg) combined with either 
Dexmedetomidine 2 µg/kg in normal saline 1 ml, Clonidine 2 µg/ kg in 
normal saline 1 ml, or corresponding volume of normal saline according 
to group assignment. Addition of Dexmedetomidine or Clonidine to 
caudal Bupivacaine significantly promoted analgesia time 16hr (14–18) 
and 12 (3–21) h, respectively] than the use of Bupivacaine  alone[5 (4–6) 
h].However, there was no statistically significant difference between 
dexmedetomidine and clonidine as regards the analgesia time  
9. Low Dose Intrathecal Clonidine With Bupivacaine Improves Onset 
And Duration Of Block With Haemodynamic Stability:    Archna 
Koul, Deepanjali Pant, Jayshree Sood et  al  Indian Journal of 
Anesthesia 2009 ,Volume :53 , Issue :4 ; 450-454 Forty children 
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undergoing inguinal hernia repair were randomly given caudal injection 
with 0.75 ml.kg -1 of Bupivacaine (0.25%) and Clonidine 2 µg.kg -1 in 
Group C or 0.75 ml.kg -1 of Bupivacaine (0.25%) alone in Group B after 
induction of anaesthesia. Postoperatively duration of analgesia, OPS 
score (observational pain / discomfort scale), Sedation score, heart rate 
and blood pressure were recorded. In this study  duration of analgesia was 
significantly longer (p< 0.001) in Group C (10.25 hours) as compared to 
4.55 hours in Group B. Bradycardia, hypotension and sedation were not 
observed in Group C. The addition of Clonidine in caudal blocks 
prolongs postoperativepain relief in children and is safe alternative to 
Bupivacaine alone in paediatric daycare surgeries 
10. Randomized controlled trial comparing morphine or clonidine 
with bupivacaine for caudal analgesia in children undergoing upper 
abdominal surgery    Singh R, Kumar N, Singh P, British journal of 
Anaesthesia 2010,doi:10,1093; Oct 14    They conducted a prospective, 
randomized, double-blind controlled study in 50 ASA I-II children  aged 
1-6 yr undergoing upper abdominal surgery. They were divided into two 
groups to receive either morphine 30 µg /kg(MB) or Clonidine 2 
µg/kg(CB) in Bupivacaine 0.2% (1.25 ml/kg) for caudal analgesia. The 
duration of analgesia (FLACC scale) and sedation and side-effects were 
observed. They concluded that Caudal Clonidine 2 µg /kg in Bupivacaine 
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0.2% provides a longer duration of analgesia and sedation compared with 
caudal morphine 30 µg /kg in Bupivacaine 0.2% without significant side-
effects 
11.Caudal Ropivacaine-Clonidine  :A better postoperative analgesic 
approach   Sukhminder Jit Singh Bajwa, Jasbir Kaur, Sukhwinder Kaur 
Bajwa, Geetika Bakshi et al . Indian journal of anesthesia 2010  54(3) 
:226-230   A total of 44 ASA-I paediatric patients between the ages of 1 
and 9 years, scheduled for elective hernia surgery, were enrolled in this 
randomised double-blind study. The caudal block was administered with 
Ropivacaine 0.25%(Group I) and Ropivacaine 0.25% and Clonidine 2 
µg/kg (Group II) after induction of general anaesthesia.They concluded 
that, a caudal block with 0.25% of isobaric Ropivacaine combined with 2 
µg/kg of Clonidine provides efficient analgesia intra-operatively and 
prolonged duration of analgesia post-operatively 
12. Low Dose Intrathecal Clonidine With Bupivacaine Improves 
Onset And Duration Of Block With Haemodynamic Stability  Hema 
Saxena, Sudhir Kumar Singh, S.K. Ghildiyal     The Internet Journal of 
Anesthesiology 2010 vol 23, number 1.  They studied 80 adult patients 
belonging to ASA I & II scheduled for below umbilical surgery under 
spinal anaesthesia dividing them randomly into four groups. Control 
group received 13.5mg of 0.5% hyperbaric Bupivacaine(group 1) Study 
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group received 15µg of Clonidine (group2), 30µg Clonidine (group3), 
37.5µ of Clonidine (group4) made to 3ml volume with13.5mg of 0.5% 
hyperbaric Bupivacaine. The onset of block was fast , duration of 
analgesia & motor block was longer in  all Clonidine groups. 
13.Randomized controlled trial comparing morphine or clonidine 
with bupivacaine for caudal analgesia in children undergoing upper 
abdominal surgery  Aruna parameswari, Mahesh vakamudi, Dhev 
Anand  Indian journal of anaesthesia vol 54, issue 5, sep-oct 2010.    
100 children of age 1-3 yrs who underwent below umbilical surgery were 
enrolled in this study. Group A received caudal anaesthesia with 1ml/ Kg 
of 0.25% Bupivacaine in NS. Group B received 1ml/Kg of 0.25% 
Bupivacaine with 1µ/Kg of Clonidine in NS. Mean duration of analgesia 
was significantly longer in group B (593.4±423.3min) than in groupA 
(288.7±259.1) 
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MATERIALS AND METHODS 
Study design: 
This  is a prospective, randomised, double blind, comparative 
study, done to compare the efficacy and safety of caudal  Clonidine with 
Bupivacaine and plain Bupivacaine for intraoperative and postoperative 
analgesia in children. 
The study was carried out in 60 children at Govt.Rajaji hospital, Madurai for 
surgeries of lower abdomen and perineum lasting for  45 – 90 minutes, in 
the year 2009-2010.  
Inclusion criteria: 
The children in the age group of 1 -10 years  and weighing 5-20Kgs were 
selected for the study. Only patients of ASA I physical status were chosen to 
avoid the influence of the associated diseases. They were divided into 2 
groups of 30 each. Group B received caudal Bupivacaine and group BC 
received caudal Clonidine with Bupivacaine. 
Exclusion criteria: 
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i. H/o allergic reaction to local anaesthetics  
ii. Bleeding diathesis 
iii. Neurological disease 
iv. Local sepsis 
v. Grossly abnormal sacral anatomy 
Preanaesthetic evaluation: 
1. History 
2. Clinical examination 
 3. Relevant investigations – haemoglobin,  urine     analysis 
4. Informed consent from parents 
5. All children were kept nil per oral for 6 hours prior to surgery 
Induction and maintenance: 
After recording the pulse, blood pressure and saturation, an 
intravenous line was secured and isolyte-P infusion started. Mask induction 
was done with incremental doses of  Halothane and 70% Nitrous oxide in 
Oxygen  
Caudal block was performed in lateral Sim’s position. The sacral 
hiatus was identified using the landmarks –the coccyx and sacral cornu. The 
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area was thoroughly cleaned and draped. A 23G needle was inserted in the 
hiatus at an angle of 45°.A distinct pop off was felt once the sacrococcygeal 
membrane was pierced, after which the angle of the needle was lowered to 
20° and advanced to 2-3mm. After negative aspiration for blood and CSF, 
the drug was injected. Following  injection, the patient was placed in the 
supine position and 10minutes later, the surgeons were allowed to proceed. 
Anaesthesia maintained with 0.5% Halothane and 70%N₂O in O₂ and 
patient breathing spontaneously. 
Group I :  
These children received 1ml/Kg of 0.25% Bupivacaine ( 0.9% NaCl 
as diluent ) total dose not exceeding 3mg/Kg 
Group II:  
These children received Clonidine 2µg/Kg with 0.25% Bupivacaine  
to a total volume of 1ml/Kg. Total volume not exceeding 20ml 
Intraoperative monitoring: 
Heart rate, blood pressure, saturation were monitored. 
Decrease of MAP or HR more than 30% from the baseline values was 
defined as severe hypotension or bradycardia, respectively which was 
treated accordingly. 
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    At the beginning of skin closure, anaesthesia was discontinued. 
Postoperative monitoring: was done at every 15 minutes for 3 Hours   
i. Heart rate 
ii. Saturation (SpO₂) 
iii. Blood pressure 
iv. 4 point sedation score  
v. Objective pain scale score 
vi. First supported standing 
Side effects like nausea, vomiting, bradycardia, respiratory depression 
were noted. 
If the child complained of pain or if the objective pain scale score was 
more than 11,rectal Paracetamol(15mg/Kg) was given as rescue 
analgesic.  
4 point sedation score 
1 – Asleep, not arousable by verbal contact 
2 – Asleep, arousable by verbal contact 
3 – Drowsy/ not sleeping 
4 – Alert/ awake 
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OBJECTIVE PAIN SCALE SCORE 
PARAMETERS FINDING POINTS 
SYSTOLIC BP 
+ 10% before operation 
+ 20% before operation 
+ 30% before operation 
1 
2 
3 
CRYING 
Not crying 
Crying but responds to tender loving care 
(TLC) 
Crying and no response to TLC 
1 
2 
3 
MOVEMENTS 
None 
Restless 
Thrashing 
1 
2 
3 
AGITATION 
Patient asleep or calm 
Mildly agitated 
Hysterical 
1 
2 
3 
COMPLAINS OF 
PAIN 
Asleep or states no pain 
Cannot localize pain 
Can localize pain 
1 
2 
3 
 
60 
 
OBSERVATIONS AND RESULTS 
The observation was recorded for both the groups as shown in the master 
chart 
Statistical tools 
The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of 
computer using Epidemiological Information Package (EPI 2008).  
 Using this software, range, frequencies, percentages, means, 
standard deviations, chi square and  'p'  values were calculated. Kruskul 
Wallis chi-square test was used to test the significance of difference 
between quantitative variables. A 'p' value less than 0.05 is taken to 
denote significant relationship. 
 
RESULTS 
Table 1 shows the demographic variables of the patients selected for the 
study.(Graph 1, 2, 3) 
The age of the children was in the range of 1-6 years with a mean of 
2.83±1.51 years in group B and 2.67±1.49 years in group BC. The weight 
of the children ranged from 8-20Kg with a mean of 12.97±3.21Kg in 
group B and 12.47 ±3.51Kg in group BC 
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GRAPH 1: AGE DISTRIBUTION 
 
 
 
 
 
 
 
 
GRAPH 2 : SEX DISTRIBUTION 
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Table-1 DEMOGRAPHIC VARIABLES 
Variable 
GroupB 
MEAN±SD 
Group BC 
MEAN ±SD 
‘p’ value 
 
Significance 
Age(years) 2.83±1.51 2.67±1.49 0.638 Not significant 
Sex 
Male 
Female 
 
12 
18 
 
16 
14 
 
0.4376 
 
Not significant 
 
Weight 
(kg) 
12.97±3.21 12.47±3.51 0.5279 Not significant 
 
Hence the two groups were comparable with respect to age, sex and 
weight 
 
DURATION OF SURGERY: (table 2)  
The duration of surgery was around 40-70 min in both the groups 
with  a mean duration of 49.33 ±8.58min  in group B and 50.67±8.68min 
in group BC which is not statistically significant.  
(Graph 4) 
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GRAPH 3 : WEIGHT 
 
 
 
 
 
 
 
GRAPH 4 : DURATION OF SURGERY 
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TABLE 2: DURATION OF SURGERY 
Group B 
MEAN±SD 
Group BC 
MEAN±SD 
              
               ‘p’ value 
49.33±8.58 50.67±8.68 0.5187 
 
BASELINE HAEMODYNAMIC PARAMETERS(Table 3): The 
preoperative pulse rate, blood pressure, Hb saturation in the two groups 
were comparable  in both groups. 
 
TABLE 3: BASELINE HAEMODYNAMIC PARAMETERS 
VARIABLE Group  B 
MEAN±SD 
Group  BC 
MEAN±SD 
‘p’ 
VALUE 
SIGNIFICANCE
PULSE 
RATE 
118.8±10.8 115.4±11.2 0.3104 Not significant 
Systolic BP 
Diastolic BP 
101.4±9.5 
70.7±6.4 
100.5±9.6 
68.5±4.5 
0.7209 
0.5384 
Not significant 
Not significant 
SpO₂ 99.73±0.58 99.37±0.96 0.117 Not significant 
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DURATION OF ANALGESIA( table 4 &5) : 
 The time elapsed from the onset of caudal block to the objective 
pain scale score >11 was around 165min - 230min in group B with a 
mean of 196.5 ± 16.6min. In group BC duration of analgesia ranged from 
265min to 345min with a mean of 300.2 ± 21.9min which is statistically 
significant.(Graph 4 & 5) 
 
 
TABLE  4 : DURATION OF ANALGESIA 
GROUP 
MEAN±SD 
(min) 
P SIGNIFICANCE 
B 196.5±16.6 
0.0001 Significant 
BC 300.2±21.9 
 
 
TABLE 5: OBJECTIVE PAIN SCALE SCORE 
GROUP MEAN±SD p  SIGNIFICANCE 
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B 6.54±0.25  
0.0001 
Significant 
BC 5 
 
 
GRAPH 4 : DURATION OF ANALGESIA 
 
 
 
 
 
 
 
 
GRAPH 5 : OBJECTIVE PAIN SCALE SCORE 
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SEDATION: 
As seen in table 6, the sedation score in BC group was 2.49 ± 0.11 as 
compared to 2.97±0.09 in group B which shows that the quality of 
sedation was better in group BC than group B.(Graph 6) 
 
 
TABLE 6 : SEDATION SCORE 
GROUP MEAN±SD p  SIGNIFICANCE 
B 2.97±0.09  
0.0001 
 
Significant BC 2.49±0.11 
 
 
MOTOR RECOVERY (table 7):  
The motor recovery was assessed from  the  time  required for first 
supported standing. The time required for first supported standing in 
group B was 160-210 minutes with a mean of 184.5±13.3 min. In group 
BC it was around 175-210 minutes with a mean of 190.3±9.2 min. There 
was no significant difference between the two groups in the time taken 
for motor recovery. (Graph 7) 
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GRAPH 6 : 4 POINT SEDATION SCORE 
 
 
 
 
 
 
 
 
 
GRAPH 7: MOTOR RECOVERY 
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TABLE 7: TIME OF FIRST SUPPORTED  STANDING 
GROUP MEAN±SD p  SIGNIFICANCE 
B 184.5± 13.3  
0.0678 
Not significant 
BC 190.3± 9.2 
 
HAEMODYNAMIC PARAMETERS  (table 8) 
PULSE RATE: 
 The change in the  pulse rate between the two groups was 
significant. The average pulse rate was 116.7±9.3 /minute in group B and 
104.4±7.7 / minute in group BC.  This is statistically significant between 
the two groups.(graph 8) 
BLOOD PRESSURE:  
The mean systolic BP was 100.8±6.6mmHg  group B and 
98.3±6.8mmHg in group which is not statistically significant. Diastolic 
BP was 68.5± 4.5mmHg in group B and 67±3.3mmHg in group BC 
which is not statistically significant.(graph 9 & 10) 
HAEMOGLOBIN SATURATION (SPO₂) : 
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SPO₂ in group was around 98.93±0.91 % in group B and  
98.5±0.94% in group BC which is statistically not significant.(graph 11) 
GRAPH 8: PULSE RATES AT VARIOUS INTERVALS 
 
 
 
 
 
 
 
 
GRAPH 9 : SYSTOLIC BP 
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GRAPH 10: DIASTOLIC BP 
 
 
 
 
 
 
 
 
GRAPH 11:SpO₂ 
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TABLE 8: HAEMODYNAMIC PARAMETERS 
VARIABLE Group B 
MEAN±SD 
Group BC 
MEAN±SD
p 
VALUE 
SIGNIFICANCE 
Pulse rate 116.7±9.3 104.4±7.7 0.0001 Significant 
Systolic 
Diastolic 
100.8±6.6 
68.5±4.5 
98.3±6.8 
67±3.3 
0.1294 
0.1675 
Not significant 
Not significant 
SpO₂ 98.93±0.91 98.5±0.94 0.0778 Not sigmificant 
 
 
SIDE EFFECTS:  
Vomiting was observed in 2 patients who underwent herniotomy in 
group BC. There was no side effects in group B patients. The observed 
difference between the two groups is statistically not 
significant(p=0.6574, >0.05) 
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DISCUSSION 
Pain is an unpleasant subjective sensation which can only be 
experienced and not expressed, especially in children; who would seem to 
conceal their feelings when suffering from pain. The primary reason to 
treat or prevent pain is humanitarian. This is even more important in 
children who rely completely on their parents or care givers for their well 
being.  
The concept of postoperative pain relief and its utilisation in the 
paediatric age group has improved dramatically over the recent years. The 
society of Paediatric anaesthesia, at its 15th annual meeting in 2001 
clearly defined the alleviation of pain as a “basic human right”, 
irrespective of age, medical condition, treatment, primary service 
response, for the patient care or medical institution. Langlade et al 
suggested that the post operative pain treatment must be included in the 
anaesthetic planning even before induction of anaesthesia, adopting the 
idea of ‘managing pain before it occurs’. Acute pain is the pain associated 
with a brief episode of tissue injury or inflammation, such as that caused 
by surgery, or trauma. In most of such cases, the intensity of pain 
diminishes steadily over a period of time.  
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Ideal anaesthetic technique should be targeted at three sites – the 
periphery, the sensory flow in nerves and cells in the central nervous 
system. The administration of an analgesic before any tissue damage 
takes place could interfere with and reduce the magnitude of nociception 
and thereby prevent a state of hyersensitisation. 
The various methods of providing pain relief have some side 
effects which prohibit their use, for eg, narcotics in children, because of 
their respiratory depression, the objection to needles in the case of 
parenterally administered analgesics. 
Caudal route was chosen for the study as it is the simplest and 
safest techniques in paediatric surgery with a success rate of allowing 
single shot injection of local anaesthetics and additives that prolong the 
postoperative analgesia. By this regional technique, problems and 
complications of intubation and polypharmacy due to general anaesthesia 
are avoided.  
         The two groups were comparable with respect to age, sex, weight 
and duration of surgery. The preoperative pulse rate, blood pressure and 
saturation was also comparable. 
HAEMODYNAMIC STABILITY: 
In both the groups there was no significant alteration in the 
postoperative  blood pressure and saturation though the pulse rate was 
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significantly low in group BC but not to the extent of haemodynamic 
instability. 
SEDATION:  Sedation and hence patient comfortability  as assessed 
from 4 point sedation score was better in group BC compared to group B 
 
 
ANALGESIA:   
   Pain intensity was assessed in this study by objective pain scale 
score (OPSS). The OPS score is a reliable and sensitive tool in evaluating 
postoperative pain in children. 
The mean duration of analgesia for caudal Bupivacaine was 196.5 
minutes. (165minutes - 230minutes). In group BC duration of analgesia 
was 300.2 minutes  (265-345 minutes). 
MOTOR RECOVERY: 
Motor recovery was assessed from the time for first supported 
standing postoperatively which was similar in both the groups. 
The results of the study done by W. Klimscha et al,(anaesthesia- 
analgesia1998) showed that addition of Clonidine 1µg/Kg or 2µg/Kg to 
0.25% Bupivacaine significantly prolongs the duration of analgesia 
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compared with plain Bupivacaine or Bupivacaine plus 1:200000 
epinephrine.  
Similarly, Lee JJ et al in their study used Clonidine in the dose of 2 
µg/kg in children under going orthopaedic surgery and found significant 
prolongation of analgesia (9.8 hrs) as compared to Bupivacaine (5.2 hrs). 
The results of the study done, is comparable to the above similar studies 
with respect to analgesic effects of Clonidine. 
In contrast to the study done in 36 chidren  by Joshi W, Connelly 
NR, Freeman K, Reuben SS, in which there was no significant increase in 
the duration of analgesia but there was vomiting in 8 cases in clonidine 
group, this study shows significant prolongation of the duration of 
analgesia and only 2 cases reported to have vomiting. 
 
 
 
 
SUMMARY 
This study was carried out at govt. Rajaji hospital, Madurai, in 60 
children of age 1- 10 years, with ASA physical status I who underwent 
infraumbilical surgeries. They were divided into two groups of 30 each. 
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Group I : caudal 1ml/Kg of 0.25% Bupivacaine 
Group II : caudal Clonidine 2µg/Kg with Bupivacaine as above. 
All children were induced and maintained with halothane and 70% N₂O  
in O₂. This study shows that   
1.Clonidine when added to caudal Bupivacaine provided longer duration 
of analgesia when compared to Bupivacaine alone. 
2. Patient comfortability in terms of sedation and quality of analgesia is 
better in Clonidine - Bupivacaine group 
3. Cardiovascular stability was similar in both the groups 
4. Duration of motor blockade were similar in both the groups. 
5. There was no side effect in group B while there was vomiting in 2 
patients in Clonidine – Bupivacaine group which is statistically 
insignificant.  
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CONCLUSION 
 
 
From this study it is concluded that Clonidine 2µg/Kg when combined 
with 0.25% Bupivacaine 1ml/Kg in caudal anaesthesia provides efficious 
pain relief and comfortability for longer duration in children undergoing 
infraumbilical surgeries, without any significant side effects. 
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